| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $881.7M | +2.4% |
| Cost of Revenue | $481.8M | -0.1% |
| Gross Profit | $399.9M | +5.7% |
| R&D Expense | $91.7M | +6.9% |
| SG&A Expense | $164.5M | +3.5% |
| Operating Income | $110.5M | +7.2% |
| Pre-tax Income | $83.7M | -3.9% |
| Income Tax | $10.9M | -17.1% |
| Net Income | $72.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.1M | +4.9% |
| Accounts Receivable | $139.4M | +1.2% |
| Inventory | $149.4M | -11.1% |
| Current Assets | $415.3M | -1.2% |
| Total Assets | $1.23B | -1.2% |
| Current Liabilities | $139.2M | -15.4% |
| Long-term Debt | $349.4M | -18.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $120.1M | +32.3% |
| Capital Expenditures | $20.0M | +1.6% |
| Investing Cash Flow | -$19.9M | +53.2% |
| Financing Cash Flow | -$97.9M | -62.7% |
| Free Cash Flow | $100.1M | +40.7% |
| -1.6% |
| EPS (Basic) | $2.03 | -2.4% |
| EPS (Diluted) | $2.02 | -1.9% |
| Total Liabilities |
| $552.6M |
| -16.7% |
| Stockholders' Equity | $673.5M | +16.6% |